Search Results

There are 793 results for: content related to: Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial

  1. You have free access to this content
    The Pharmacology and Therapeutic Use of Dabigatran Etexilate

    The Journal of Clinical Pharmacology

    Volume 53, Issue 1, January 2013, Pages: 1–13, Spinler Sarah

    Article first published online : 24 JAN 2013, DOI: 10.1177/0091270011432169

  2. Dabigatran etexilate: What do hospitalists need to know?

    Journal of Hospital Medicine

    Volume 7, Issue 3, March 2012, Pages: 262–269, Amer Zeidan, Bishoy Faltas and Michael Streiff

    Article first published online : 29 NOV 2011, DOI: 10.1002/jhm.996

  3. A proposal for dose-adjustment of dabigatran etexilate in atrial fibrillation guided by thrombin time

    British Journal of Clinical Pharmacology

    Volume 78, Issue 3, September 2014, Pages: 599–609, Paul K. L. Chin, Daniel F. B. Wright, David M. Patterson, Matthew P. Doogue and Evan J. Begg

    Article first published online : 21 AUG 2014, DOI: 10.1111/bcp.12364

  4. An evaluation of oral dabigatran etexilate pharmacokinetics and pharmacodynamics in hemodialysis

    The Journal of Clinical Pharmacology

    Volume 54, Issue 8, August 2014, Pages: 901–909, Jo-Anne S. Wilson, Kerry B. Goralski, Steven D. Soroka, Matthew Morrison, Paula Mossop, Lekha Sleno, Yan Wang and David R. Anderson

    Article first published online : 28 MAY 2014, DOI: 10.1002/jcph.335

  5. You have free access to this content
    Decrease in the oral bioavailability of dabigatran etexilate after co-medication with rifampicin

    British Journal of Clinical Pharmacology

    Volume 74, Issue 3, September 2012, Pages: 490–500, Sebastian Härtter, Michael Koenen-Bergmann, Ashish Sharma, Gerhard Nehmiz, Ute Lemke, Wolfgang Timmer and Paul A. Reilly

    Article first published online : 6 AUG 2012, DOI: 10.1111/j.1365-2125.2012.04218.x

  6. You have full text access to this OnlineOpen article
    Practical use of dabigatran etexilate for stroke prevention in atrial fibrillation

    International Journal of Clinical Practice

    Volume 67, Issue 6, June 2013, Pages: 516–526, K. Huber, S. J. Connolly, A. Kher, F. Christory, G.-A. Dan, R. Hatala, R. G. Kiss, B. Meier, B. Merkely, B. Pieske, T. Potpara, J. Stępińska, N. Vene Klun, D. Vinereanu and P. Widimský

    Article first published online : 5 APR 2013, DOI: 10.1111/ijcp.12147

  7. You have free access to this content
    The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects

    British Journal of Clinical Pharmacology

    Volume 64, Issue 3, September 2007, Pages: 292–303, Joachim Stangier, Karin Rathgen, Hildegard Stähle, Dietmar Gansser and Willy Roth

    Article first published online : 15 MAY 2007, DOI: 10.1111/j.1365-2125.2007.02899.x

  8. Evaluation of Dabigatran Bleeding Adverse Reaction Reports in the FDA Adverse Event Reporting System during the First Year of Approval

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 34, Issue 6, June 2014, Pages: 561–569, Kevin W. McConeghy, Adam Bress, Dima M. Qato, Coady Wing and Edith A. Nutescu

    Article first published online : 18 MAR 2014, DOI: 10.1002/phar.1415

  9. Thrombin inhibitors: surgical considerations and pharmacology

    ANZ Journal of Surgery

    Volume 83, Issue 4, April 2013, Pages: 215–221, Omar Breik, Rami Tadros and Peter Devitt

    Article first published online : 6 FEB 2013, DOI: 10.1111/ans.12078

  10. You have free access to this content
    Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions

    Journal of Clinical Pharmacy and Therapeutics

    Volume 39, Issue 2, April 2014, Pages: 118–135, J. W. Cheng and G. Barillari

    Article first published online : 3 JAN 2014, DOI: 10.1111/jcpt.12122

  11. You have free access to this content
    Antiinflammatory and antifibrotic effects of the oral direct thrombin inhibitor dabigatran etexilate in a murine model of interstitial lung disease

    Arthritis & Rheumatism

    Volume 63, Issue 5, May 2011, Pages: 1416–1425, Galina S. Bogatkevich, Anna Ludwicka-Bradley, Paul J. Nietert, Tanjina Akter, Joanne van Ryn and Richard M. Silver

    Article first published online : 27 APR 2011, DOI: 10.1002/art.30255

  12. Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor, With Coadministration of Digoxin

    The Journal of Clinical Pharmacology

    Volume 52, Issue 2, February 2012, Pages: 243–250, Dr Joachim Stangier, Ms Hildegard Stähle, Dr Karin Rathgen, Dr Willy Roth, Dr Kathrin Reseski and Dr Thomas Körnicke

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270010393342

  13. Factors influencing doctors’ selection of dabigatran in non-valvular atrial fibrillation

    Journal of Evaluation in Clinical Practice

    Volume 19, Issue 5, October 2013, Pages: 938–943, Cindy Huang, Michele Siu, Lily Vu, Soo Wong and Jaekyu Shin

    Article first published online : 26 JUL 2012, DOI: 10.1111/j.1365-2753.2012.01886.x

  14. You have free access to this content
    Practical Considerations for Using Novel Oral Anticoagulants in Patients With Atrial Fibrillation

    Clinical Cardiology

    Volume 37, Issue 1, January 2014, Pages: 32–47, Irene Savelieva and A. John Camm

    Article first published online : 19 NOV 2013, DOI: 10.1002/clc.22204

  15. You have free access to this content
    Direct thrombin inhibitors

    British Journal of Clinical Pharmacology

    Volume 72, Issue 4, October 2011, Pages: 581–592, Catherine J. Lee and Jack E. Ansell

    Article first published online : 9 SEP 2011, DOI: 10.1111/j.1365-2125.2011.03916.x

  16. You have free access to this content
    Proceedings of the Thrombosis and Hemostasis summit of North America: Research abstracts

    American Journal of Hematology

    Volume 87, Issue S1, May 2012, Pages: S146–S200,

    Article first published online : 10 APR 2012, DOI: 10.1002/ajh.23168

  17. Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor, Are Not Affected by Moderate Hepatic Impairment

    The Journal of Clinical Pharmacology

    Volume 48, Issue 12, December 2008, Pages: 1411–1419, Dr Joachim Stangier, Hildegard Stähle, Dr Karin Rathgen, Dr Willy Roth and Dr Kasra Shakeri-Nejad

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270008324179

  18. You have free access to this content
    Performance of coagulation tests in patients on therapeutic doses of dabigatran: a cross-sectional pharmacodynamic study based on peak and trough plasma levels

    Journal of Thrombosis and Haemostasis

    Volume 11, Issue 8, August 2013, Pages: 1493–1502, E. M. Hawes, A. M. Deal, D. Funk-Adcock, R. Gosselin, C. Jeanneret, A. M. Cook, J. M. Taylor, H. C. Whinna, A. M. Winkler and S. Moll

    Article first published online : 14 AUG 2013, DOI: 10.1111/jth.12308

  19. You have free access to this content
    Effects of the direct thrombin inhibitor dabigatran on ex vivo coagulation time in orthopaedic surgery patients: a population model analysis

    British Journal of Clinical Pharmacology

    Volume 62, Issue 5, November 2006, Pages: 527–537, Karl-Heinz Liesenfeld, Hans G. Schäfer, Iñaki F. Trocóniz, Christiane Tillmann, Bengt I. Eriksson and Joachim Stangier

    Article first published online : 28 APR 2006, DOI: 10.1111/j.1365-2125.2006.02667.x

  20. You have free access to this content
    Oral bioavailability of dabigatran etexilate (Pradaxa®) after co-medication with verapamil in healthy subjects

    British Journal of Clinical Pharmacology

    Volume 75, Issue 4, April 2013, Pages: 1053–1062, Sebastian Härtter, Regina Sennewald, Gerhard Nehmiz and Paul Reilly

    Article first published online : 15 MAR 2013, DOI: 10.1111/j.1365-2125.2012.04453.x